GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
Learn more about severe asthma
Find out more about the trial and what it is trying to achieve
See who is involved in running this study
Details of funding support for the trial